{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Neurocognitive+function&page=2", "query": { "intervention": "Neurocognitive function", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Neurocognitive+function&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-10T15:33:26.683Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03086421", "title": "Social Emotional Development in Young Children With Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Solid Tumor, Childhood", "Brain Tumor, Pediatric" ], "interventions": [ { "name": "Questionnaires", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "4 Years to 6 Years" }, "enrollment_count": 119, "start_date": "2017-07-11", "completion_date": "2028-06", "has_results": false, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT03086421" }, { "nct_id": "NCT01080521", "title": "Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cognitive Side Effects of Cancer Therapy", "Malignant Ovarian Epithelial Tumor", "Ovarian Brenner Tumor", "Ovarian Carcinosarcoma", "Ovarian Choriocarcinoma", "Ovarian Clear Cell Cystadenocarcinoma", "Ovarian Dysgerminoma", "Ovarian Embryonal Carcinoma", "Ovarian Endometrioid Adenocarcinoma", "Ovarian Mixed Germ Cell Tumor", "Ovarian Mucinous Cystadenocarcinoma", "Ovarian Polyembryoma", "Ovarian Sarcoma", "Ovarian Seromucinous Carcinoma", "Ovarian Serous Cystadenocarcinoma", "Ovarian Teratoma", "Ovarian Yolk Sac Tumor", "Stage I Ovarian Cancer", "Stage IA Fallopian Tube Cancer", "Stage IA Ovarian Cancer", "Stage IA Ovarian Germ Cell Tumor", "Stage IB Fallopian Tube Cancer", "Stage IB Ovarian Cancer", "Stage IB Ovarian Germ Cell Tumor", "Stage IC Fallopian Tube Cancer", "Stage IC Ovarian Cancer", "Stage IC Ovarian Germ Cell Tumor", "Stage II Ovarian Cancer", "Stage IIA Fallopian Tube Cancer", "Stage IIA Ovarian Cancer", "Stage IIA Ovarian Germ Cell Tumor", "Stage IIB Fallopian Tube Cancer", "Stage IIB Ovarian Cancer", "Stage IIB Ovarian Germ Cell Tumor", "Stage IIC Fallopian Tube Cancer", "Stage IIC Ovarian Cancer", "Stage IIC Ovarian Germ Cell Tumor", "Stage IIIA Fallopian Tube Cancer", "Stage IIIA Ovarian Cancer", "Stage IIIA Ovarian Germ Cell Tumor", "Stage IIIA Primary Peritoneal Cancer", "Stage IIIB Fallopian Tube Cancer", "Stage IIIB Ovarian Cancer", "Stage IIIB Ovarian Germ Cell Tumor", "Stage IIIB Primary Peritoneal Cancer", "Stage IIIC Fallopian Tube Cancer", "Stage IIIC Ovarian Cancer", "Stage IIIC Ovarian Germ Cell Tumor", "Stage IIIC Primary Peritoneal Cancer", "Stage IV Fallopian Tube Cancer", "Stage IV Ovarian Cancer", "Stage IV Ovarian Germ Cell Tumor", "Stage IV Primary Peritoneal Cancer", "Undifferentiated Ovarian Carcinoma" ], "interventions": [ { "name": "Cognitive Assessment", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 247, "start_date": "2010-04", "completion_date": "2018-01-27", "has_results": false, "last_update_posted_date": "2018-04-12", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 182, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Burbank, California + 129 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Burbank", "state": "California" }, { "city": "Burbank", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01080521" }, { "nct_id": "NCT07546409", "title": "Effects of Exogenous Ketones on Cognitive Function in Older Adults With Prediabetes?", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prediabetes", "Healthy (Controls)" ], "interventions": [ { "name": "Ketone Monoester (KE)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "60 Years to 75 Years" }, "enrollment_count": 20, "start_date": "2025-05-20", "completion_date": "2027-05-31", "has_results": false, "last_update_posted_date": "2026-07-02", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 2, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT07546409" }, { "nct_id": "NCT03660774", "title": "A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Haemophilia A", "Haemophilia B" ], "interventions": [ { "name": "No treatment given", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Novo Nordisk A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "MALE", "summary": "1 Year to 21 Years · Male only" }, "enrollment_count": 563, "start_date": "2018-09-27", "completion_date": "2019-10-11", "has_results": false, "last_update_posted_date": "2019-11-22", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 22, "location_summary": "Los Angeles, California • Orange, California • San Diego, California + 19 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03660774" }, { "nct_id": "NCT03963804", "title": "Objective Brain Function Assessment of mTBI/Concussion", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Brain Injuries, Traumatic", "Concussion, Mild", "Concussion, Intermediate", "Concussion, Severe", "Concussion, Brain" ], "interventions": [ { "name": "BrainScope Ahead 300iP", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "BrainScope Company, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "13 Years to 25 Years" }, "enrollment_count": 268, "start_date": "2018-06-11", "completion_date": "2019-03-29", "has_results": false, "last_update_posted_date": "2019-05-28", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 4, "location_summary": "Fayetteville, Arkansas • Miami, Florida • East Lansing, Michigan + 1 more", "locations": [ { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Miami", "state": "Florida" }, { "city": "East Lansing", "state": "Michigan" }, { "city": "Rochester", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03963804" }, { "nct_id": "NCT05903573", "title": "Training Response Artificial Intelligence Network (TRAIN)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Amnestic Mild Cognitive Impairment" ], "interventions": [ { "name": "Cognitive Training", "type": "BEHAVIORAL" }, { "name": "Computerized Cognitive Stimulation", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "55 Years", "maximum_age": "100 Years", "sex": "ALL", "summary": "55 Years to 100 Years" }, "enrollment_count": 75, "start_date": "2023-10-09", "completion_date": "2028-04-30", "has_results": false, "last_update_posted_date": "2025-12-04", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05903573" }, { "nct_id": "NCT00853580", "title": "A Randomized Placebo-Controlled Study of Lovastatin in Children With Neurofibromatosis Type 1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neurofibromatosis Type 1" ], "interventions": [ { "name": "Lovastatin ™", "type": "DRUG" }, { "name": "placebo", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "8 Years to 15 Years" }, "enrollment_count": 146, "start_date": "2009-07", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-03-12", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 11, "location_summary": "Birmingham, Alabama • Los Angeles, California • Washington D.C., District of Columbia + 8 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853580" }, { "nct_id": "NCT02404194", "title": "Targeted Cognitive Training in Clinical High Risk (CHR) for Psychosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Clinical High Risk for Psychosis" ], "interventions": [ { "name": "Targeted Cognitive Training", "type": "BEHAVIORAL" }, { "name": "Computer Games", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "30 Years", "sex": "ALL", "summary": "15 Years to 30 Years" }, "enrollment_count": 139, "start_date": "2015-03", "completion_date": "2021-02-15", "has_results": false, "last_update_posted_date": "2022-12-02", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02404194" }, { "nct_id": "NCT03546387", "title": "Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Pediatric Retinoblastoma", "Retinoblastoma" ], "interventions": [ { "name": "Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V)", "type": "OTHER" }, { "name": "California Verbal Learning Test, Children's Version", "type": "OTHER" }, { "name": "Beery Developmental Test of Visual Motor Integration, 6th edition", "type": "OTHER" }, { "name": "Grooved Pegboard Test", "type": "OTHER" }, { "name": "Behavior Assessment System for Children/Parent Report", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 75, "start_date": "2018-05-07", "completion_date": "2027-05-07", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03546387" }, { "nct_id": "NCT02957682", "title": "Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Praluent (Alirocumab)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "40 Years to 85 Years" }, "enrollment_count": 2176, "start_date": "2016-11-02", "completion_date": "2020-03-05", "has_results": true, "last_update_posted_date": "2021-05-07", "last_synced_at": "2026-09-10T15:33:26.683Z", "location_count": 73, "location_summary": "Auburn, Alabama • Birmingham, Alabama • Mobile, Alabama + 63 more", "locations": [ { "city": "Auburn", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Gatos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02957682" } ] }